
Odigaba M 1500mcg/75mg Tablet
Marketer
Provectus Life Sciences
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Odigaba M 1500mcg/75mg Tablet
Gabapentinoid combination therapy, Odigaba M (1500mcg/75mg), is a prescription medication indicated for neuropathic pain management. Its mechanism involves modulating nerve cell calcium channel activity, thus reducing pain signals. Furthermore, this medication offers neuroprotective effects and promotes nerve cell repair. Administer Odigaba M orally, with or without food, ideally before sleep. Consistent daily dosing is crucial for maintaining therapeutic drug levels. Follow your physician's prescribed dosage and duration meticulously, as this medication possesses habit-forming potential. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is contraindicated without prior medical consultation. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, tremor, visual blurring, dry mouth, vertigo, and somnolence. Avoid activities requiring alertness until the drug's effects are known. Most side effects are mild and resolve spontaneously. Weight gain is possible; regular exercise and a balanced diet are recommended to mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Complete disclosure of all concurrent medications is essential, as interactions may compromise efficacy or alter the drug's action. Notify your physician of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Odigaba M 1500mcg/75mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Odigaba M 1500mcg/75mg Tablet
Managing neuropathic pain
Major Benefits of Odigaba M 1500mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Odigaba M 1500mcg/75mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Odigaba M 1500mcg/75mg Tablet:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Odigaba M 1500mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Odigaba M 1500mcg/75mg Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
How Odigaba M 1500mcg/75mg Tablet works:
Odigaba M tablets (1500mcg/75mg) combine methylcobalamin and pregabalin to alleviate neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signaling by modulating nerve cell calcium channels. This dual action targets the underlying causes of nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Odigaba M 1500mcg/75mg tablets and alcohol may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Odigaba M 1500mcg/75mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Odigaba M 1500mcg/75mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Odigaba M 1500mcg/75mg Tablet might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Odigaba M 1500mcg/75mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Odigaba M 1500mcg/75mg Tablet in patients with liver disease is likely safe. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Odigaba M 1500mcg/75mg Tablet :
Should you forget to take a dose of Odigaba M 1500mcg/75mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Odigaba M 1500mcg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neurology |
